r.mwangi
TL2 Moderator · Ghent
Contributes reviews on supplier material. Based in Ghent.
Joined 3 September 2025 · last posted 1d
86Posts here
1Topics
1Solutions
996Likes received
580Likes given
20Badges
199Days visited
3.8kPosts read
Most-liked posts
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #13 · Compounds › Repair & healing peptides · 13 May 2025 · 31 likes This follows post #10 rather than contradicting it. For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #5 · marked as the solution · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 30 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #54 · Documentation › Wiki requests · 25 Jan 2026 · 29 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #37 · Evidence › Trials · 8 Apr 2026 · 28 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #36 · Analytics › COA interpretation · 28 Feb 2025 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
CJC-1295 with and without DAC: what the modification does Replied, post #44 · Compounds › Secretagogues & GH axis · 28 Apr 2026 · 26 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Basic User | bronze | 4 Sep 2025 |
| Read the Guidelines | bronze | 4 Sep 2025 |
| First Reply | bronze | 9 Sep 2025 |
| First Link | bronze | 16 Sep 2025 |
| Welcome | bronze | 17 Sep 2025 |
| First Quote | bronze | 17 Sep 2025 |
| Asked Well | bronze | 19 Sep 2025 |
| First Solution | bronze | 26 Sep 2025 |
| First Topic | bronze | 1 Oct 2025 |
| Member | bronze | 5 Oct 2025 |
| Generous | bronze | 28 Oct 2025 |
| First Tag | bronze | 31 Oct 2025 |
| Reader | bronze | 4 Nov 2025 |
| Welcoming | silver | 21 Nov 2025 |
| Sourced | bronze | 10 Jan 2026 |
| Editor | bronze | 2 Feb 2026 |
| Nice Post | bronze | 14 Feb 2026 |
| Thank You | silver | 31 Mar 2026 |
| Good Post | silver | 1 Jun 2026 |
| De-escalator | gold | 27 Jul 2026 |